Back to News
Market Impact: 0.35
The 'ChatGPT for doctors,' OpenEvidence, was valued at $15 billion in a new funding round
Source: businessinsider.com
Artificial IntelligenceHealthcare & BiotechPrivate Markets & Venture
Health AI startup OpenEvidence raised $250 million at a $15 billion valuation, according to people familiar with the matter. The financing underscores strong private-market investor appetite for clinical artificial-intelligence platforms, with OpenEvidence positioned as a "ChatGPT for doctors."
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.70
More News
- Nasdaq defies Nvidia impact as Huang faces espionage affair probe
- Jensen Huang’s $21 billion net worth in AI rout—Nvidia’s recovery will be ‘capped’ after he admitted affair with alleged Chinese spy
- Nvidia's CEO turmoil gives newly empowered Democrats fresh ammunition in pursuit of oversight
- Key AI chip index just broke its long-term trendline. What history says happens next
- Banks, investors grow wary of AI debt, spooked by market selloff
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval